LACRISERT® Provides All-Day Dry Eye Relief in a Single Dose*
LACRISERT® comfortably provides all-day, Dry Eye relief without the inconvenience of artificial tears (ATs)
Dropless, Preservative-Free, All-Day Relief
LACRISERT® is a convenient Dry Eye treatment for you:
- Dissolves comfortably and creates a soothing layer of protection1,2
- Requires just a single dose daily*
- Provides long-lasting, all-day relief3
- Frees you from the temporary relief and frequent dosing of ATs
- No preservatives to cause irritation or damage, even with long-term use1,2
Nearly 4 in 5 Patients...Preferred All-Day Relief With LACRISERT® Over ATs2
Speak with your eye care professional today.
LACRISERT® is indicated in patients with moderate to severe Dry Eye syndromes, including keratoconjunctivitis sicca. LACRISERT® is indicated especially in patients who remain symptomatic after an adequate trial of therapy with artificial tear solutions. LACRISERT® is also indicated for patients with exposure keratitis, decreased corneal sensitivity, and recurrent corneal erosions.
Important Safety Information
LACRISERT® is contraindicated in patients who are hypersensitive to hydroxypropyl cellulose. The following adverse reactions have been reported in patients treated with LACRISERT® but were, in most instances, mild and temporary: blurring of vision, eye discomfort or irritation, matting or stickiness of eyelashes and red eyes. If improperly placed, LACRISERT® may result in corneal abrasion.
*In most patients, one LACRISERT® placed into each eye once daily is effective in providing all-day symptom relief. Some patients may require twice-daily use for optimal results.1
Reference: 1. Lacrisert [package insert]. Lawrenceville, NJ: Aton Pharma, Inc.; 2007. 2. Katz JI, Kaufman HE, Breslin C, Katz IM. Slow-release artificial tears and the treatment of keratitis sicca. Ophthalmology. 1978;85(8):787-793. 3. Hill JC. Slow-release artificial tear inserts in the treatment of dry eyes in patients with rheumatoid arthritis. Br J Ophthalmol. 1989;73(2):151-154.
